Cargando…
Trends in treatment of Peyronie’s disease in adult men in the United States from 2008 to 2017 – results from an encounter and claims database
Treatments for Peyronie’s Disease (PD) include oral medications, intralesional injections and surgery. Collagenase Clostridium histolyticum (CCh) is the only FDA approved treatment for PD. We sought to examine current trends in treatment of PD across the United States. Using data in the MarketScan D...
Autores principales: | Moghalu, Odinachi I., Das, Rupam, Horns, Joshua, Campbell, Alexander, Hotaling, James M., Pastuszak, Alexander W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8494877/ https://www.ncbi.nlm.nih.gov/pubmed/33828265 http://dx.doi.org/10.1038/s41443-021-00430-x |
Ejemplares similares
-
Regional Variation in The Incidence and Prevalence of Peyronie’s Disease in The United States – Results from an Encounters and Claims Database
por: Moghalu, Odinachi I., et al.
Publicado: (2022) -
Increased Risk of Cancer in Men With Peyronie’s Disease: A Cohort Study Using a Large United States Insurance Claims Database
por: Pastuszak, Alexander W., et al.
Publicado: (2019) -
Peyronie's disease: What's around the bend?
por: Bilgutay, Aylin N., et al.
Publicado: (2016) -
Serious complications of collagenase clostridium histiolyticum injection for Peyronie’s disease: more than meets the eye!
por: Hobaugh, Christopher, et al.
Publicado: (2017) -
AB004. Peyronie’s disease: 2017 update
por: Lue, Tom F.
Publicado: (2017)